CLOs on the Move

Milestone Centers

www.aemhmr.org

 
Milestone Centers Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Milestone Centers Inc. is based in Pittsburgh, PA. You can find more information on Milestone Centers Inc. at www.aemhmr.org
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Metabolon

Metabolon, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Durham, NC. To find more information about Metabolon, Inc., please visit www.metabolon.com

Cellenkos Incorporated

Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.

Ascend Wellness

Ascend Group Partners is a vertically integrated cannabis cultivator, processor, and dispensary operator focused on the Massachusetts, Illinois, and Michigan markets. We seek to foster a robust and inclusive cannabis industry through a premium, unmatched customer-focused retail experience.

Biolux Research

Biolux Research Ltd. is a world leader in the development of innovative Light Accelerated™ technology and products for use in orthodontics, implantology, and other dentistry markets.

Genalyte

Since 2007, Genalyte has been guided by the vision of taking a single drop of blood, performing panels of tests and returning accurate and reproducible results within a few minutes. We launched our first instrument in 2012 in the pharmaceutical industry and academia for a range of healthcare applications including autoimmune disease monitoring, screening of cancer biomarkers, testing for infectious agents and detecting anti-drug antibodies. By reducing tests to a microscopic size in a highly multiplex environment on the surface of silicon chips we are able to generate more information from a smaller sample in less time than conventional techniques.